The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Monday, November 23, 2020
Inhibrx has announced updated interim results from a Phase 1 clinical trial evaluating the efficacy and safety of INBRX-109 in patients with ...
read more
Monday, November 23, 2020
Regeneron announced the antibody cocktail casirivimab and imdevimab administered together, a therapy currently being investigated for use in COVID-19,...
read more
Monday, November 23, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Friday, November 20, 2020
Rafael announced the FDA has granted Fast Track designation for the Company’s lead compound CPI-613 for metastatic pancreatic cancer.
read more
Friday, November 20, 2020
Ampio announced the second group in the Phase I inhaled Ampion clinical study is being treated following clearance by the SMC who found Ampion to be ...
read more
Thursday, November 19, 2020
Arena announced topline results from the Phase 2b ADVISE clinical trial evaluating etrasimod for moderate-to-severe atopic dermatitis.
read more
Wednesday, November 18, 2020
Impel NeuroPharma has submitted a NDA for INP104 or DHE to the FDA for the acute treatment of migraine headaches with or without aura.
read more
Tuesday, November 17, 2020
Pierre Fabre announced the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its ...
read more
Tuesday, November 17, 2020
BioMarin announced the Company is expanding its clinical program for vosoritide, an investigational analog of C-type Natriuretic Peptide, with two new...
read more
Tuesday, November 17, 2020
AstraZeneca Pharmaceuticals
Calquence, a selective BTK inhibitor, has been approved in the EU for chronic lymphocytic leukemia.
read more
Monday, November 16, 2020
Moderna announced the DSMB for the Phase 3 study of mRNA-1273 has informed informed the company the trial has met the statistical criteria pre-...
read more
Monday, November 16, 2020
Senhwa announced CARE in Georgia, received a May Proceed letter from the FDA to begin a phase II IIT evaluating Silmitasertib, a novel orally ...
read more
Monday, November 16, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Friday, November 13, 2020
OSE Immunotherapeutics has announced successful completion of its human ex vivo study with CoVepiT.
read more
Friday, November 13, 2020
Assembly Biosciences provided an update on the ongoing open-label Phase 2 extension study of vebicorvir in patients with chronic HBV infection.
read more